NCT05815407View on ClinicalTrials.gov

Expressiona and Diagnostic Potential of miRNAs in NSCLC

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Non Small Cell Lung Cancer
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

11231

Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt, Cairo

All Listed Sponsors
collaborator

National Cancer Institute, Cairo University, Egypt

UNKNOWN

lead

Al-Azhar University

OTHER

NCT05815407 - Expressiona and Diagnostic Potential of miRNAs in NSCLC | Biotech Hunter | Biotech Hunter